CMPX
Compass Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing antibody-based therapies for cancer and autoimmune disease, working on programs such as bispecific antibodies and antibody-drug conjugates. It grew out of Boston's biotech ecosystem, founded by drug-development scientists in the early 2010s to build a pipeline of novel antibody medicines aimed at solid tumors. The company takes its name from the guiding idea of using antibodies to "point" the immune system, like a compass, toward cancer cells — a naming quirk that frames its whole mission.
CUSIP: 20454B104HealthcareUS1 holder
Recent Activity
2026Q2
1 sell
-150.1K shares(-29.1%)
-150.1K shares(-29.1%)
2026Q1
1 buy
+514.8K shares
+514.8K shares